Australia's largest stock trading and investment forum Australia's #1 stock forum

IHL

0.00%

4.1¢ incannex healthcare limited

Very much appreciated, great insights as always and I’ll use...

First 20 Last

Share
Profile

Follow
Wasabi193

1,526 Posts.

379

27/04/23

17:45

Post #: 67486796
Share

Originally posted by thevinnys: ↑

Welcome Wasabi

2. What environment would be needed to raise "investor expectations" for the future of Incannex and a possible increase in its' Market Cap Value?

A. IHL-42X - 2023-24

>> IHL-42X - Opening Clinical Trials for Phase 2/3 in the U.S.A. Sleep Clinics will raise the Profile of IHL-42X as a possible alternative medication for OSA
>> IHL-42X - Preliminary Trial Results from USA Trials from Phase 2 (with success), then progressing immediately into Phase 3 will also raise the profile.

B. PSI-GAD 2023-24

>> Completion of the Phase 2 Monash Trial by the end of the year and the possible release of the results early next year will raise the profile of PSI as a possible therapy for GAD.

And with what appears to be mostly bi-partisan support for Psychedelics Therapies in US politics that bodes well too for a lead into the opening of an IND with the FDA around the same time as MAPS PBC receiving approval from the FDA for its MDMA Treatment for PTSD, with approx 1.9M Veterans eligible for treatment. As I have said previously there is commentary stating that any FDA approval for any indications using any Psychedelics will be worth Billions for that company and lift the profile of the whole Pyschedelics Industry.

C. Psychedelics Clinics 2023-4

>> Peter Widdows's reputation precedes him! Read up on his experience.

As I have posted today, plans have been made to use clinics as Real World Research Labs, and refer to commentary from@Flectionaltoo.
As@rhino78I think mentioned recently, our clinics will be available to treat other patients for other indications also.
Some Clinics in the USA such as those operated by Numinous (https://numinus.com/) have had some positive feedback for the services they provide to the Psychedelics Industry.
Our Psychennex Clinics will lift the PUBLIC profile of our PSI-GAD program, subject to the success of the trial and the opening of the 1st clinic by the end of the year.

AB & C IMO are the real catalysts for an increase in IHL's Profile for New Investors' Expectations, this is not a short-term journey as@kingkevconsistently reminds all investors.
https://hotcopper.com.au/threads/ihl-incannex-holders-research.6278647/page-730?post_id=67298653

Good luck @Wasabi193

Expand

Very much appreciated, great insights as always and I’ll use this info as the foundation to get back up to speed.

IHL Price at posting: 12.0¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

TRP

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

PEC

Perpetual sniffs TREOs beyond 4000ppm at Raptor play in Brazil

MM1

Geochemical work at Newington picks up gold and copper anomalies for Midas

BGL

Bellevue aims for 45% production increase by FY 2028, announces $150M placement